Skip to main content
SpringerLink
Log in

Adalimumab

Anti-NMDA-receptor encephalitis and multiple sclerosis: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Ford H, et al. A rare case of concurrent anti-NMDA-receptor encephalitis and first presentation Multiple Sclerosis in the setting of adalimumab treatment for psoriatic arthritis. Multiple Sclerosis Journal 28 (Suppl.): 31, No. 4, Dec 2022. Available from: URL: http://doi.org/10.1177/13524585221135362 [abstract]

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adalimumab. Reactions Weekly 1943, 20 (2023). https://doi.org/10.1007/s40278-023-32905-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-32905-2

Search

Navigation